CLINICAL_TRIALS
trial_result
· 2025-03-06
Clinical Trial Update: A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine [Phase 3]
Summary
Phase 3 trial evaluating soticlestat in Dravet syndrome or Lennox-Gastaut syndrome patients with prior fenfluramine exposure was terminated; results have been p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS) | Phase 3 | Status: TERMINATED | Results posted: 2025-03-06